Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE: Peripartum Cardiomyopathy Registry and Selenium Sub-study
NCT03081949Phase 4Completed
- Sponsor
- Aminu Kano Teaching Hospital
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Aminu Kano Teaching Hospital. Primary endpoint: Prevalence of peripartum cardiomyopathy in Nigeria at 6 months. Started Jun 2017; status: completed.
Beyond the preview
Go deeper on NCT03081949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081949.